Xencor
XNCR
24.26
-0.10
-0.41%
Xencor
US · XNCR
#2825 by market cap
Listed 1970
24.26
-0.10
-0.41%
Live - 5344 symbols - heartbeat 541s ago
· 2026-10-08 07:58
Pre-market
24.26
0.00%
After-hours
24.26
0.00%
- Market cap
- 1.80B
- P/E (TTM)i
- -11.23
- P/Bi
- 3.58
- EPSi
- -1.24
- Div yieldi
- 0.00%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on XNCR?
Anonymous reader poll. Unscientific, not investment advice.
About Xencor
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Pasadena, CA.
- Founded
- 1997
- CEO
- Dr. Bassil I. Dahiyat, PhD.
- Employees
- 260
- Headquarters
- Pasadena, California, United States of America
- Fiscal year end
- 12-31
- Website
- xencor.com
Company profile
- Exchange
- US
- Symbol
- XNCR
- Market-cap rank
- #2825
- Listing date
- 1970-01-01
- Market cap
- 1.80B
- Float cap
- 1.32B
- Shares out
- 74.35M
- Float shares
- 54.25M
Sectors & themes
Quote time 2026-10-08 07:58:21 · For reference only, not investment advice and not tailored to your situation.